Literature DB >> 5950347

Classification of leprosy according to immunity. A five-group system.

D S Ridley, W H Jopling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5950347

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN： 0148-916X


× No keyword cloud information.
  716 in total

1.  Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy.

Authors:  S N Cho; R V Cellona; L G Villahermosa; T T Fajardo; M V Balagon; R M Abalos; E V Tan; G P Walsh; J D Kim; P J Brennan
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Inhibition of apoptosis by ionomycin and zinc in peripheral blood mononuclear cells (PBMC) of leprosy patients.

Authors:  A Gupta; V K Sharma; H Vohra; N K Ganguly
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

3.  Importance of nasal lesions in early lepromatous leprosy.

Authors:  R P Barton
Journal:  Ann R Coll Surg Engl       Date:  1975-12       Impact factor: 1.891

4.  Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire.

Authors:  M Mempel; B Flageul; F Suarez; C Ronet; L Dubertret; P Kourilsky; G Gachelin; P Musette
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 5.  A patient with erythema nodosus leprosum and Chagas cardiopathy: challenges in patient management and review of the literature.

Authors:  Maria Ângela B Trindade; Noemia B Carvalho; Elaini C Belfort; Carla Pagliari; Erika Gakiya; Neusa Y Sakai-Valente; Gil Benard; Maria A Shikanai-Yasuda
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

6.  Transcriptional changes that characterize the immune reactions of leprosy.

Authors:  Kathryn M Dupnik; Thomas B Bair; Andressa O Maia; Francianne M Amorim; Marcos R Costa; Tatjana S L Keesen; Joanna G Valverde; Maria do Carmo A P Queiroz; Lúcio L Medeiros; Nelly L de Lucena; Mary E Wilson; Mauricio L Nobre; Warren D Johnson; Selma M B Jeronimo
Journal:  J Infect Dis       Date:  2014-11-14       Impact factor: 5.226

7.  Lsr2 peptides of Mycobacterium leprae show hierarchical responses in lymphoproliferative assays, with selective recognition by patients with anergic lepromatous leprosy.

Authors:  Mehervani Chaduvula; A Murtaza; Namita Misra; N P Shankar Narayan; V Ramesh; H K Prasad; Rajni Rani; R K Chinnadurai; Indira Nath
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

8.  From genome-based in silico predictions to ex vivo verification of leprosy diagnosis.

Authors:  Annemieke Geluk; John S Spencer; Kidist Bobosha; Maria C V Pessolani; Geraldo M B Pereira; Sayera Banu; Nadine Honoré; Stephen T Reece; Murdo MacDonald; Bishwa Raj Sapkota; Chaman Ranjit; Kees L M C Franken; Martha Zewdie; Abraham Aseffa; Rabia Hussain; Mariane M Stefani; Sang-Nae Cho; Linda Oskam; Patrick J Brennan; Hazel M Dockrell
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

9.  Thymopentin treatment in patients with chemotherapy-resistant lepromatous leprosy.

Authors:  A Castells; J Terencio; A Ramirez; E Sundal; K Bolla
Journal:  Surv Immunol Res       Date:  1985

10.  Humoral immunity in leprosy: immunoglobulin G and M antibody responses to Mycobacterium leprae in relation to various disease patterns.

Authors:  J Touw; E M Langendijk; G L Stoner; A Belehu
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.